Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:06am, Thursday, 05'th Sep 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Worried About a Stock Market Crash: Buy These 2 Stocks Now
09:01am, Thursday, 05'th Sep 2024
If you're just a bit more worried about a market sell-off going into the fourth quarter, you're not alone.
5 Dividend Kings Provide Perfect Passive Income Streams for Retirement
08:13am, Thursday, 05'th Sep 2024
24/7 Wall St. Insights Social Security is not enough to provide for a comfortable retirement.
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
07:55am, Thursday, 05'th Sep 2024
Dividend cuts and suspensions can come suddenly and investors should always be on the lookout for warning signs. A strong track record for dividend growth is by no means a guarantee that a company wil
Johnson & Johnson wins over longtime holdout for talc settlement, WSJ reports
04:12pm, Wednesday, 04'th Sep 2024
Johnson & Johnson is expected to secure more votes in favor of its talc settlement plan after increasing its offer to claimants, which has swayed a longtime legal adversary, WSJ reported on Wednesday,
Johnson & Johnson (JNJ) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
02:03pm, Wednesday, 04'th Sep 2024
Johnson & Johnson (NYSE:JNJ ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 10:45 AM ET Company Participants Joaquin Duato - CEO & Chairman John Reed - Head of Pharma R&D C
3 Dividend Stocks to Double Up on Right Now
08:26am, Wednesday, 04'th Sep 2024
Verizon offers a high-yielding and steadily rising dividend. Johnson & Johnson pays a very healthy dividend.
Johnson & Johnson (JNJ) Increases Despite Market Slip: Here's What You Need to Know
06:50pm, Tuesday, 03'rd Sep 2024
Johnson & Johnson (JNJ) concluded the recent trading session at $167.16, signifying a +0.78% move from its prior day's close.
Is Johnson & Johnson the Best Dividend Stock for You?
06:45am, Sunday, 01'st Sep 2024
Johnson & Johnson is a remarkably consistent business. A fortress-like balance sheet all but guarantees the dividend's safety.
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
01:11pm, Friday, 30'th Aug 2024
The Johnson & Johnson filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of antibody-positive patients.
Must-have stocks for passive income in 2025
12:00pm, Friday, 30'th Aug 2024
In addition to profiting from ordinary trading activities, the stock market offers opportunities for investors seeking passive income through dividend payouts.
Drop Johnson & Johnson, Pick These Steady Eddie Stocks?
08:00am, Friday, 30'th Aug 2024
If you are a Johnson & Johnson investor and have been enjoying the stock's steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita - a healthcare company focused on kidne
Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
03:18pm, Thursday, 29'th Aug 2024
Johnson & Johnson JNJ has just made a significant technical move, achieving a Golden Cross.
Marks first FDA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and reduce levels of autoantibodies Filing based on the Phase 3 V
J&J's Stock Up 12.8% in 3 Months: Time to Buy, Sell or Hold?
02:15pm, Wednesday, 28'th Aug 2024
We suggest a new investor should avoid buying J&J's stock now due to uncertainty surrounding its legal battles.
